Structure Therapeutics Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €404.58M +73.2% €16.18M -106.6% 4.0% +1.1 pp N/A N/A
    (estimated) €233.66M +∞% -€245.21M -20.5% -104.9% -1.0 pp N/A N/A
    (estimated) €0.00 +NaN% -€308.33M +19.1% N/A N/A N/A
    (estimated) €0.00 +NaN% -€258.95M +25.7% N/A N/A N/A
    (estimated) €0.00 +NaN% -€206.01M +94.8% N/A N/A N/A
    €0.00 +NaN% -€105.74M +36.7% N/A -€99.55M +49.2% N/A
    €0.00 +NaN% -€77.35M +74.6% N/A -€66.73M +68.2% N/A
    €0.00 +NaN% -€44.29M +134,781.3% N/A -€39.67M +148,394.5% N/A
    €0.00 +NaN% -€32.84K +139.7% N/A -€26.71K +117.0% N/A
    €0.00 -€13.70K N/A -€12.31K N/A

    Notifications